✦ LIBER ✦

Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis

✍ Scribed by Rebecca L. Olin; Kim E. Nichols; Mojdeh Naghashpour; Mariusz Wasik; Brenda Shelly; Edward A. Stadtmauer; Dan T. Vogl

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 161 KB
Volume: 83
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21236

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe inflammatory disorder marked by abnormal cytotoxic T and natural killer cell activity, resulting in impaired clearance of pathogen, excessive cytokine production, and continued immune system activation. Soluble IL‐2 receptor (sIL‐2R or sCD25) is typically elevated in HLH and can serve as a marker of disease activity, although its role in the pathophysiology of the disease is unclear. Here we present a case of an adult patient with steroid‐dependent HLH who was treated successfully with daclizumab, a monoclonal anti‐CD25 antibody, allowing successful withdrawal of steroid therapy without an increase in symptoms. Am. J. Hematol., 2008. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Successful treatment of an Epstein-Barr

Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody

✍ Bernard, F. ;Sarran, N. ;Margueritte, G. ;Barneon, G. ;Astruc, J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

Treatment with monoclonal anti–tumor nec

Treatment with monoclonal anti–tumor necrosis factor α antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis

✍ Madelon M. Maurice; Wiebo L. Van Der Graaff; Angela Leow; Ferdinand C. Breedveld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views